AMENDMENT AND RESTATEMENT OF THE VACCINEX, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • May 15th, 2024 • Vaccinex, Inc. • Pharmaceutical preparations • New York
This Amendment and Restatement (this “Amendment”), dated as of [•], 2024 (the “Effective Date”), is made and entered into by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and [•] (the “Holder”) and amends the Common Stock Purchase Warrant to purchase up to [•] shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at an exercise price of $[•] per share, originally issued by the Company to the Holder on [•], 202[3][4] (such number and price, as adjusted to reflect the Company’s February 19, 2024 reverse stock split (the “Reverse Stock Split”)) (the “Warrant”).
